Archive | Cancer in the News

FDA accepts application for binimetinib-encorafenib combination for BRAF-mutated melanoma

The FDA accepted for review new drug applications that seek the use of the COMBO450 regimen to treat patients with BRAF-mutant advanced, unresectable or metastatic melanoma, according to the drugs’ manufacturer.

Read the full story

Posted in Melanoma In The News, FDA

Melanoma Journal Articles for September 2017

Primary medical therapy for BRAF V600E-mutant melanoma brain metastases—is this good enough?

Read the full story

Posted in Journal Articles

FDA Grants LN-144 Fast Track Status for Melanoma

The FDA has granted LN-144, an adoptive cell therapy that uses tumor-infiltrating lymphocyte (TIL) technology developed by Iovance Biotherapeutics, a fast track designation for the treatment of patients with advanced melanoma.

Read the full story

Posted in Melanoma In The News, FDA

Melanoma Journal Articles for August 2017

BMJ Case Reports 2017; doi:10.1136/bcr-2017-221430 Symbiotic lymph node metastasis from breast cancer and melanoma   Molecular medicine Reports Grb2-associated binder 2 expression and its roles in uveal melanoma invasion Meiling Chen, Yuehua Li, Xiuning Sun, Baogang Zhang, Wei Li, Shuxiao Wang, Xuetao Zhu, Feng Li, Lihong Shi   Published online on: August 3, 2017 https://doi.org/10.3892/mmr.2017.7151 Oncology Letters Mechanisms […]

Read the full story

Posted in Journal Articles

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories